{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T15:50:07Z","timestamp":1709308207110},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1093\/fampra\/cmi055","type":"journal-article","created":{"date-parts":[[2005,7,9]],"date-time":"2005-07-09T00:25:04Z","timestamp":1120868704000},"page":"523-528","source":"Crossref","is-referenced-by-count":18,"title":["Do herpes zoster patients receive antivirals? A Dutch national survey in general practice"],"prefix":"10.1093","volume":"22","author":[{"given":"Wim","family":"Opstelten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit A","family":"van Essen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel GM","family":"Moons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert JM","family":"van Wijck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois G","family":"Schellevis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis J","family":"Kalkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo JM","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,7,8]]},"reference":[{"key":"key\n\t\t\t\t20171012084632_B1","doi-asserted-by":"crossref","unstructured":"Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med1995; 155:1605\u20131609.","DOI":"10.1001\/archinte.1995.00430150071008"},{"key":"key\n\t\t\t\t20171012084632_B2","doi-asserted-by":"crossref","unstructured":"Hope-Simpson RE, MRCS. The nature of herpes zoster: a long-term study and a new hypothesis. Proc Royal Soc Med1965; 58:9\u201320.","DOI":"10.1177\/003591576505800106"},{"key":"key\n\t\t\t\t20171012084632_B3","unstructured":"Alper BS, Lewis PR. Treatment of postherpetic neuralgia: a systematic review of the literature. J Fam Pract2002; 5:121\u2013128."},{"key":"key\n\t\t\t\t20171012084632_B4","doi-asserted-by":"crossref","unstructured":"Cobo M, Foulks GN, Liesegang T, Lass J, Sutphin J, Wilhelmus K et al. Observations on the natural history of herpes zoster ophthalmicus. Curr Eye Res1987; 6:195\u2013199.","DOI":"10.3109\/02713688709020090"},{"key":"key\n\t\t\t\t20171012084632_B5","doi-asserted-by":"crossref","unstructured":"Kost RG, Straus SE. Postherpetic neuralgia\u2013pathogenesis, treatment, and prevention. N Engl J Med1996; 335:32\u201342.","DOI":"10.1056\/NEJM199607043350107"},{"key":"key\n\t\t\t\t20171012084632_B6","doi-asserted-by":"crossref","unstructured":"Guidelines for the management of shingles. report of a working group of the British Society for the Study of Infection (BSSI). J Infect1995; 30:193\u2013200.","DOI":"10.1016\/S0163-4453(95)90624-X"},{"key":"key\n\t\t\t\t20171012084632_B7","doi-asserted-by":"crossref","unstructured":"Balfour HHJ. Antiviral Drugs. N Engl J Med1999; 340:1255\u20131268.","DOI":"10.1056\/NEJM199904223401608"},{"key":"key\n\t\t\t\t20171012084632_B8","doi-asserted-by":"crossref","unstructured":"Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med1999; 130:922\u2013932.","DOI":"10.7326\/0003-4819-130-11-199906010-00017"},{"key":"key\n\t\t\t\t20171012084632_B9","doi-asserted-by":"crossref","unstructured":"Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med2000; 342:635\u2013645.","DOI":"10.1056\/NEJM200003023420906"},{"key":"key\n\t\t\t\t20171012084632_B10","doi-asserted-by":"crossref","unstructured":"Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med2002; 347:340\u2013346.","DOI":"10.1056\/NEJMcp013211"},{"key":"key\n\t\t\t\t20171012084632_B11","doi-asserted-by":"crossref","unstructured":"Johnson RW. Herpes zoster and postherpetic neuralgia. Optimal treatment. Drugs Aging1997; 10:80\u201394.","DOI":"10.2165\/00002512-199710020-00002"},{"key":"key\n\t\t\t\t20171012084632_B12","doi-asserted-by":"crossref","unstructured":"Gross G, Schofer H, Wassilew S, Friese K, Timm A, Guthoff R et al. Herpes zoster guideline (1) of the German Dermatology Society (DDG). J Clin Virol2003; 26:277\u2013289.","DOI":"10.1016\/S1386-6532(03)00005-2"},{"key":"key\n\t\t\t\t20171012084632_B13","unstructured":"Peyramond D, Chidiac C, Lucht F, Perronne C, Saimot AG, Soussy JC et al. Management of infections due to the varicella-zoster virus. 11th consensus conference on anti-infectious therapy of the French-speaking Society of Infectious Diseases (SPILF). Eur J Dermatol1998; 8:397\u2013402."},{"key":"key\n\t\t\t\t20171012084632_B14","unstructured":"EBM Guidelines. www.ebm-guidelines.com2004."},{"key":"key\n\t\t\t\t20171012084632_B15","unstructured":"Bradley SF. Infections. In Jones R (ed.) Oxford Textbook of Primary Medical Care. Oxford: Oxford University Press; 2004, 1245."},{"key":"key\n\t\t\t\t20171012084632_B16","doi-asserted-by":"crossref","unstructured":"Dworkin RH. Prevention of postherpetic neuralgia. Lancet1999; 353:1636\u20131637.","DOI":"10.1016\/S0140-6736(99)00003-3"},{"key":"key\n\t\t\t\t20171012084632_B17","doi-asserted-by":"crossref","unstructured":"Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract2002; 19:471\u2013475.","DOI":"10.1093\/fampra\/19.5.471"},{"key":"key\n\t\t\t\t20171012084632_B18","doi-asserted-by":"crossref","unstructured":"Westert GP, Schellevis FG, Bakker DHd, Groenewegen PP, Bensing JM, Zee Jvd. Monitoring health inequalities through General Practice: the Second Dutch Narional Survey of General Practice. Eur J Public Health2005; 15:59\u201365.","DOI":"10.1093\/eurpub\/cki116"},{"key":"key\n\t\t\t\t20171012084632_B19","doi-asserted-by":"crossref","unstructured":"Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, Cippolle M, Schuller R et al. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. Anesth Analg2004; 98:336\u2013342.","DOI":"10.1213\/01.ANE.0000093390.94921.4A"},{"key":"key\n\t\t\t\t20171012084632_B20","unstructured":"Database. ENC. www.Europe.eu.int\/comm\/euronet."},{"key":"key\n\t\t\t\t20171012084632_B21","unstructured":"MIXOR. http:\/\/tigger.uic.edu\/~hedeker\/mix.html. 2004."},{"key":"key\n\t\t\t\t20171012084632_B22","doi-asserted-by":"crossref","unstructured":"Opstelten W, van Wijck AJM, van Essen GA, Buskens E, Bak AAA, Kalkman CJ et al. The PINE study: rationale and design of a randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly [ISRCTN32866390]. BMC Anesthesiology2004; 4.","DOI":"10.1186\/1471-2253-4-2"},{"key":"key\n\t\t\t\t20171012084632_B23","doi-asserted-by":"crossref","unstructured":"Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology2004; 62:1545\u20131551.","DOI":"10.1212\/01.WNL.0000123261.00004.29"},{"key":"key\n\t\t\t\t20171012084632_B24","unstructured":"Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? J Fam Pract2000; 49:255\u2013264."},{"key":"key\n\t\t\t\t20171012084632_B25","doi-asserted-by":"crossref","unstructured":"Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med1995; 123:89\u201396.","DOI":"10.7326\/0003-4819-123-2-199507150-00002"},{"key":"key\n\t\t\t\t20171012084632_B26","doi-asserted-by":"crossref","unstructured":"Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother1995; 39:1546\u20131553.","DOI":"10.1128\/AAC.39.7.1546"},{"key":"key\n\t\t\t\t20171012084632_B27","doi-asserted-by":"crossref","unstructured":"Cobo LM, Foulks GN, Liesegang T, Lass J, Sutphin JE, Wilhelmus K et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology1986; 93:763\u2013770.","DOI":"10.1016\/S0161-6420(86)33678-9"},{"key":"key\n\t\t\t\t20171012084632_B28","doi-asserted-by":"crossref","unstructured":"Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med1996; 125:376\u2013383.","DOI":"10.7326\/0003-4819-125-5-199609010-00004"},{"key":"key\n\t\t\t\t20171012084632_B29","doi-asserted-by":"crossref","unstructured":"Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage1997; 13:327\u2013331.","DOI":"10.1016\/S0885-3924(97)00077-8"},{"key":"key\n\t\t\t\t20171012084632_B30","doi-asserted-by":"crossref","unstructured":"Opstelten W, van Wijck AJ, Stolker RJ. Interventions to prevent postherpetic neuralgia: cutaneous and percutaneous techniques. Pain2004; 107:202\u2013206.","DOI":"10.1016\/j.pain.2003.10.021"}],"container-title":["Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/fampra\/article-pdf\/22\/5\/523\/1671953\/cmi055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T05:57:49Z","timestamp":1586325469000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/fampra\/article\/22\/5\/523\/609114\/Do-herpes-zoster-patients-receive-antivirals-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,8]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,7,8]]},"published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/fampra\/cmi055","relation":{},"ISSN":["1460-2229","0263-2136"],"issn-type":[{"value":"1460-2229","type":"electronic"},{"value":"0263-2136","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,10]]},"published":{"date-parts":[[2005,7,8]]}}}